Pacira Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
14 Jun
Pacira Biosciences Inc. Conducted Annual Stockholders Meeting

Pacira Biosciences Inc. held its Annual Meeting of Stockholders on June 10, 2025, in Parsippany, New Jersey, and online. Stockholders approved the Amended and Restated 2011 Stock Incentive Plan, increasing the number of shares of common stock authorized for grant by 2,500,000. The election of three Class II directors was also approved. The appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An advisory vote to approve the compensation of named executive officers was not approved. An advisory vote determined the frequency of future advisory votes on executive compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001396814-25-000089), on June 13, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10